Levonorgestrel Teva (Levonorgestrel)

Levonorgestrel works by binding to progesterone receptors, suppressing the luteinizing hormone surge and thereby preventing ovulation. It also thickens cervical mucus and modifies the endometrial lining, making it less receptive to sperm and reducing the chance of implantation.

The specific dose of Levonorgestrel Teva is determined by a qualified healthcare professional based on the indication and patient factors. For emergency use, a single dose is commonly prescribed, but the exact amount and regimen should follow the prescriber’s instructions.

Levonorgestrel is not intended for use during an established pregnancy and should be avoided if pregnancy is confirmed. Limited data are available for breastfeeding; however, most guidelines consider short‑term use acceptable, though a healthcare provider should evaluate individual risk‑benefit considerations.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levonorgestrel is a progestin‑only option that is effective when taken within 72 hours of unprotected intercourse, offering a convenient single‑dose regimen. Compared with copper IUD insertion, it is less invasive but slightly less effective. Compared with ulipristal acetate, levonorgestrel may have a shorter window of efficacy but is widely available over‑the‑counter in many regions.

Levonorgestrel Teva tablets should be stored at temperatures below 25 °C, in their original packaging, and protected from moisture and direct sunlight. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Levonorgestrel Teva is taken orally, usually as a single tablet. For emergency contraception, the tablet should be swallowed with water as soon as possible after unprotected sex, preferably within the first 72 hours. Follow any additional instructions provided by the prescribing clinician.

Serious but rare risks include severe allergic reactions (anaphylaxis), ectopic pregnancy, and thromboembolic events such as deep‑vein thrombosis. Any signs of severe abdominal pain, chest discomfort, difficulty breathing, or rash should prompt immediate medical evaluation.

Levonorgestrel should be avoided by individuals who are already pregnant, have a known hypersensitivity to levonorgestrel or any tablet excipients, or have uncontrolled severe hypertension. Caution is also advised for patients with significant liver disease, active breast cancer, or a history of thromboembolic disorders; a healthcare professional should assess suitability.